Stress-induced alternative splicing modulations in brain and periphery: Acetylcholinesterase as a case study

Annals of the New York Academy of Sciences

Volumn 1148, Issue , 2008, Pages 269-281

  Shaked, Iftach ^a   Zimmerman, Gabriel ^a   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acetylcholinesterase; Alternative splicing; Neuro immune dialogue; Stress responses

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ENZYME VARIANT; MESSENGER RNA PRECURSOR;

CELL COMMUNICATION; CONFERENCE PAPER; GENE EXPRESSION; GENETIC MANIPULATION; GENOME; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; MAMMAL; MOUSE; NEUROMODULATION; NONHUMAN; RNA SPLICING; STRESS; TRANSGENE;

MAMMALIA;

EID: 57649174636     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1410.001     Document Type: Conference Paper

References (94)

1. Stamm, S. et al. 2005. Function of alternative splicing. Gene 344 : 1 20.
2. Ben-Ari, S. et al. 2006. Modulated splicing-associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants. J. Neurochem. 97 (Suppl 1 24 34.
3. Meshorer, E. & H. Soreq. 2002. Pre-mRNA splicing modulations in senescence. Aging Cell 1 : 10 16.
4. Sklan, E.H. et al. 2004. Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in health, risk factors, exercise training, and genetics study. Proc. Natl. Acad. Sci. USA 101 : 5512 5517.
5. Farchi, N. et al. 2007. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection. Eur. J. Neurosci. 25 : 87 98.
6. Farchi, N., H. Soreq & B. Hochner. 2003. Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology. J. Physiol. 546 : 165 173.
7. Mor, I. et al. 2001. Modified testicular expression of stress-associated "readthrough" acetylcholinesterase predicts male infertility. FASEB J. 15 : 2039 2041.
8. Sapolsky, R.M. 2005. The influence of social hierarchy on primate health. Science 308 : 648 652.
9. Sapolsky, R.M. 2003. Stress and plasticity in the limbic system. Neurochem. Res. 28 : 1735 1742.
10. Mezey, G. & I. Robbins. 2001. Usefulness and validity of post-traumatic stress disorder as a psychiatric category. BMJ 323 : 561 563.
11. Friedman, A. et al. 1996. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2 : 1382 1385.
12. Kaufer, D. et al. 1998. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 : 373 377.
13. Meshorer, E. et al. 2002. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295 : 508 512.
14. Sklan, E.H. et al. 2006. Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties. Biol. Psychiatry 60 : 741 751.
15. Nijholt, I. et al. 2004. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol. Psychiatry 9 : 174 183.
16. Browne, R.O. et al. 2006. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure. FASEB J. 20 : 1733 1735.
17. Ehrlich, G. et al. 1994. Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe. Genomics 22 : 288 295.
18. Shapira, M. et al. 2000. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9 : 1273 1281.
19. Meshorer, E. & H. Soreq. 2006. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29 : 216 224.
20. Soreq, H. & S. Seidman. 2001. Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2 : 294 302.
21. Andres, C. et al. 1997. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. USA 94 : 8173 8178.
22. Beeri, R. et al. 1995. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5 : 1063 1071.
23. Evron, T. et al. 2007. Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. FASEB J. 21 : 2961 2969.
24. Geyer, B.C. et al. 2007. Translational control of recombinant human acetylcholinesterase accumulation in plants. BMC Biotechnol. 7 : 27.
25. Podoly, E. et al. 2007. Long-term neuroprotection by butyrylcholinesterase and its C-terminal peptide confer in vitro suppression of amyloid fibril formation. In Chemical Warfare Agents: Chemistry Pharmacology, Toxicology and Therapeutics, 2nd ed. B. Lukey, S.M. Somani & J.A. Romano Eds 203 218. CRC Press. Boca Rator.
26. Birikh, K.R. et al. 2003. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. USA 100 : 283 288.
27. Brenner, T. et al. 2003. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J. 17 : 214 222.
28. Dori, A. et al. 2007. Readthrough acetylcholinesterase in inflammation-associated neuropathies. Life Sci. 80 : 2369 2374.
29. Kehat, R. et al. 2007. A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress. Invest. Ophthalmol. Vis. Sci. 48 : 1290 1297.
30. Argov, Z. et al. 2007. Treatment of human myasthenia with oral antisense suppression of acetylcholinesterase. Neurology. 69 : 629 630.
31. Perrier, N.A. et al. 2005. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. J. Neurochem. 94 : 629 638.
32. Meshorer, E. et al. 2004. Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J. Biol. Chem. 279 : 29740 29751.
33. Meshorer, E. et al. 2005. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Mol. Psychiatry 10 : 985 997.
34. Meshorer, E. et al. 2005. Chronic cholinergic imbalances promote brain diffusion and transport abnormalities. FASEB J. 19 : 910 922.
35. Perrier, A.L., J. Massoulie & E. Krejci. 2002. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33 : 275 285.
36. Futerman, A.H. et al. 1985. Solubilization of membrane-bound acetylcholinesterase by a phosphatidylinositol-specific phospholipase C. J. Neurochem. 45 : 1487 1494.
37. Dori, A. et al. 2005. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. Cereb Cortex 15 : 419 430.
38. Karpel, R. et al. 1994. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp. Cell Res. 210 : 268 277.
39. Karpel, R. et al. 1996. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66 : 114 123.
40. Perry, C. et al. 2007. Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia. Leukemia 21 : 1472 1480
41. Perry, C. et al. 2002. Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21 : 8428 8441.
42. Perry, C., E.H. Sklan & H. Soreq. 2004. CREB regulates AChE-R-induced proliferation of human glioblastoma cells. Neoplasia 6 : 279 286.
43. Pick, M., C. Flores-Flores & H. Soreq. 2004. From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses. Ann. N. Y. Acad. Sci. 1018 : 85 98.
44. Bryk, B. et al. 2005. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J. Neurochem. 92 : 1216 1227.
45. Kaufer, D. & H. Soreq. 1999. Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms. Curr. Opin. Neurol. 12 : 739 743.
46. Perrier, N.A. et al. 2003. Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of 'tailed' acetylcholinesterase. Eur. J. Neurosci. 18 : 1837 1847.
47. Schwienbacher, I. et al. 2006. Carbachol injections into the nucleus accumbens disrupt acquisition and expression of fear-potentiated startle and freezing in rats. Neuroscience 140 : 769 778.
48. Chandrasekharan, N.V. et al. 2002. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. USA 99 : 13926 13931.
49. Andres, C. et al. 1996. Cholinergic drug resistance and impaired spatial learning in transgenic mice overexpressing human brain acetylcholinesterase. Prog. Brain Res. 109 : 265 272.
50. Erb, C. et al. 2001. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77 : 638 646.
51. Cohen, O. et al. 2002. Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psychiatry 7 : 874 885.
52. Svedberg, M.M. et al. 2002. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. J. Mol. Neurosci. 18 : 211 222.
53. Dori, A. et al. 2005. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. Cereb Cortex 15 : 419 430.
54. Sternfeld, M. et al. 2000. Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97 : 8647 8652.
55. Gilboa-Geffen, A. et al. 2007. The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. Blood 109 : 4383 4391.
56. Rees, T. et al. 2003. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging 24 : 777 787.
57. Rees, T.M. et al. 2005. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr. Alzheimer. Res. 2 : 291 300.
58. Grisaru, D. et al. 2006. Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol. 176 : 27 35.
59. Benmoyal-Segal, L. et al. 2005. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J. 19 : 452 454.
60. Battaglia, M. & A. Ogliari. 2005. Anxiety and panic: from human studies to animal research and back. Neurosci. Biobehav. Rev. 29 : 169 179.
61. Pick, M. et al. 2004. Blood-cell-specific acetylcholinesterase splice variations under changing stimuli. Int. J. Dev. Neurosci. 22 : 523 531.
62. Changeux, J.-P. 1983. L'homme Neuronal. Fayard. Paris.
63. Holmes, C. et al. 1997. Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons. J. Neurosci. Res. 49 : 207 218.
64. Llinas, R.R. & S.A. Greenfield. 1987. On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons. Proc. Natl. Acad. Sci. USA 84 : 3047 3050.
65. Beeri, R. et al. 1997. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69 : 2441 2451.
66. Maskos, U. et al. 2005. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436 : 103 107.
67. von der Kammer, H. et al. 1998. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors. J. Biol. Chem. 273 : 14538 14544.
68. Kaufer, D. et al. 1999. Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem. Biol. Interact. 119-120 : 349 360.
69. Dong, H. et al. 2004. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J. Neurosci. 24 : 8950 8960.
70. Giacobini, E. 2003. Cholinergic function and Alzheimer's disease. Int. J. Geriatr. Psychiatry. 18 : S1 S5.
71. Cohen, O. et al. 2003. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase. J. Mol. Neurosci. 21 : 199 212.
72. Soreq, H. et al. 2005. Acetylcholinesterase as a window onto stress responses. In Handbook on Stress in the Brain Part 1, Neuro biology and Stress, Vol. 1. T. Steckler, N.H. Kalin & J.M.H.M. Reul Eds 585 608. Elsevier Science Amsterdam.
73. Blank, T. et al. 2002. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J. Neurosci. 22 : 3788 3794.
74. Ben-Shaul, Y., H. Bergman & H. Soreq. 2005. Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression. Bioinformatics 21 : 1129 1137.
75. Chan, R.Y. et al. 1998. Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273 : 9727 9733.
76. Zhang, X.J. et al. 2002. Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ. 9 : 790 800.
77. Deutsch, V.R. et al. 2002. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34 (+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp. Hematol. 30 : 1153 1161.
78. Grisaru, D. et al. 2001. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol. Med. 7 : 93 105.
79. Flores-Flores, C. et al. 2002. Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library. J. Neural. Transm. Suppl. 165 179.
80. Ofek, K. et al. 2007. Cholinergic status modulations in human volunteers under acute inflammation. J. Mol. Med. 85 : 1239 1251.
81. Borovikova, L.V. et al. 2000. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85 : 141 147.
82. Tracey, K.J. 2002. The inflammatory reflex. Nature 420 : 853 859.
83. Shytle, R.D. et al. 2004. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 89 : 337 343.
84. Wang, H. et al. 2003. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 : 384 388.
85. Pavlov, V.A. et al. 2003. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9 : 125 134.
86. Pollak, Y. et al. 2005. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann. Neurol. 57 : 741 745.
87. Evron, T. et al. 2005. RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons. Neurodegenerative Dis. 2 : 16 27.
88. Kawashima, K. & T. Fujii. 2004. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci. 9 : 2063 2085.
89. Tayebati, S.K. et al. 2002. Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J. Neuroimmunol. 132 : 147 155.
90. Szelenyi, J.G., E. Bartha & S.R. Hollan. 1982. Acetylcholinesterase activity of lymphocytes: an enzyme characteristic of T-cells. Br. J. Haematol. 50 : 241 245.
91. Evron, T. et al. 2007. Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults. Toxicology 233 : 97 107.
92. Hanada, T. & A. Yoshimura. 2002. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13 : 413 421.
93. Kovanen, P.E. et al. 2000. Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells. Blood 95 : 1626 1632.
94. Broide, R.S. et al. 1999. Manipulations of ACHE gene expression suggest non-catalytic involvement of acetylcholinesterase in the functioning of mammalian photoreceptors but not in retinal degeneration. Brain. Res. Mol. Brain Res. 71 : 137 148.